(Q36724837)

15 August 2017

1 reference

title

The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review (English)

1 reference

15 August 2017

0 references

1 reference

Eldo E Frezza

1

1 reference

PubMed ID

17268838

15 August 2017

Mitchell S Wachtel

series ordinal

2

1 reference

PubMed ID

17268838

15 August 2017

Maurizio Chiriva-Internati

series ordinal

3

1 reference

15 August 2017

1 March 2007

1 reference

Digestive Diseases and Sciences

15 August 2017

1 reference

15 August 2017

52

1 reference

15 August 2017

3

1 reference

15 August 2017

643-649

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-006-9096-2

15 August 2017

0 references

cites work

Human distribution and release of a putative new gut hormone, peptide YY

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-006-9096-2

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

12 December 2020

Glucagon-like peptide containing pathways in the regulation of feeding behaviour

1 reference

12 December 2020

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

1 reference

12 December 2020

Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships.

1 reference

12 December 2020

Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss?

1 reference

12 December 2020

Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus

1 reference

12 December 2020

Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.

1 reference

12 December 2020

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

1 reference

12 December 2020

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

12 December 2020

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

12 December 2020

A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats

1 reference

12 December 2020

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

12 December 2020

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

12 December 2020

Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36

1 reference

12 December 2020

1 reference

12 December 2020

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

1 reference

12 December 2020

Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.

1 reference

12 December 2020

Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.

1 reference

12 December 2020

GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans

1 reference

12 December 2020

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

1 reference

12 December 2020

Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas

1 reference

12 December 2020

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats

1 reference

12 December 2020

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

1 reference

12 December 2020

Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men

1 reference

12 December 2020

GLP-1 as a satiety factor in children with eating disorders

1 reference

12 December 2020

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

1 reference

12 December 2020

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

1 reference

12 December 2020

Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.

1 reference

12 December 2020

Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.

1 reference

12 December 2020

Expression of the glucagon-like peptide-1 receptor gene in rat brain.

1 reference

12 December 2020

Oral triacylglycerols regulate plasma glucagon-like peptide-1(7-36) and insulin levels in normal and especially in obese rats

1 reference

12 December 2020

Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study

1 reference

12 December 2020

Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats

1 reference

12 December 2020

Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats.

1 reference

12 December 2020

Exendin-4, a GLP-1 receptor agonist, stimulates pituitary-adrenocortical axis in the rat: Investigations into the mechanism(s) underlying Ex4 effect.

1 reference

12 December 2020

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

1 reference

12 December 2020

Identification of glucagon-like peptide-1(7-36) amide in rat brain

1 reference

12 December 2020

Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives

1 reference

12 December 2020

A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells

1 reference

12 December 2020

Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide

1 reference

12 December 2020

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

12 December 2020

Interacting appetite-regulating pathways in the hypothalamic regulation of body weight

1 reference

12 December 2020

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

12 December 2020

Characterization of glucagon-like peptide-1-(7-36)amide in the hypothalamus

1 reference

12 December 2020

Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.

1 reference

12 December 2020

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

1 reference

12 December 2020

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

1 reference

12 December 2020

Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling

1 reference

12 December 2020

Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice

1 reference

12 December 2020

Ghrelin enhances appetite and increases food intake in humans

1 reference

12 December 2020

Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.

1 reference

12 December 2020

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

1 reference

12 December 2020

1 reference

12 December 2020

Attenuated GLP-1 secretion in obesity: cause or consequence?

1 reference

12 December 2020

Developmentally and regionally regulated expression of growth hormone secretagogue receptor mRNA in rat brain and pituitary gland.

1 reference

12 December 2020

Absence of a memory effect for the insulinotropic action of glucagon-like peptide 1 (GLP-1) in healthy volunteers

1 reference

12 December 2020

Effect of GLP-1 (glucagon-like peptide 1:7-36 amide) on porcine pancreatic endocrine cell proliferation and insulin secretion

1 reference

12 December 2020

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

1 reference

12 December 2020

Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion

1 reference

12 December 2020

Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects

1 reference

12 December 2020

Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?

1 reference

12 December 2020

Ghrelin causes hyperphagia and obesity in rats.

1 reference

12 December 2020

Oxyntomodulin inhibits food intake in the rat

1 reference

12 December 2020

Effects of glucagon and glucagon-like peptide-1 on glucocorticoid secretion of dispersed rat adrenocortical cells

1 reference

12 December 2020

Model for the regulation of energy balance and adiposity by the central nervous system

1 reference

12 December 2020

Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.

1 reference

12 December 2020

Interrelationship among insulin, glucagon and somatostatin secretory responses to exendin-4 in the perfused rat pancreas

1 reference

12 December 2020

Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus.

1 reference

12 December 2020

CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors.

1 reference

12 December 2020

Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.

1 reference

12 December 2020

Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism.

1 reference

12 December 2020

Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.

1 reference

12 December 2020

Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues

1 reference

12 December 2020

Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test

1 reference

12 December 2020

Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system.

1 reference

12 December 2020

A role for ghrelin in the central regulation of feeding

1 reference

12 December 2020

Central pre-proglucagon derived peptides: opportunities for treatment of obesity

1 reference

12 December 2020

Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.

1 reference

12 December 2020

Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39)

1 reference

12 December 2020

Glucagon-like peptide-1 in the pathogenesis of obesity

1 reference

12 December 2020

Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus.

1 reference

12 December 2020

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

1 reference

12 December 2020

Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.

1 reference

12 December 2020

10.1007/S10620-006-9096-2

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17268838